Ignite Creation Date:
2024-05-06 @ 7:05 AM
Last Modification Date:
2024-10-26 @ 11:44 AM
Study NCT ID:
NCT02465892
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2015-06-03
Brief Title:
Pillars4Life Trial
Sponsor:
Duke University
Organization:
Duke University
Study Overview
Official Title:
Pillars4Life Randomized Control Trial
Status:
COMPLETED
Status Verified Date:
2016-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
Pillars4Life
Brief Summary:
This study aims to explore whether cancer patients can benefit from completing the Pillars4Life online coping program This randomized control trial will have half its subject completing the program and the other half receiving standard care in order to measure whether the program is beneficial in dealing with stress anxiety and particularly chronic pain that often accompany a cancer diagnosis
Detailed Description:
Subjects will complete three online surveys as part of the study Each subject who completes the first survey will be randomized to either the control group who receive standard care from their care team or to complete the 9-week Pillars4Life curriculum Subjects completing the Pillars4Life program will select a course daytime that works for them from those offered Each week the program will send an email approximately 15 minutes before class time with a link Subjects will click the link to go to the classroom where they will enter their name and phone number The program will call the number provided and the subject will listen to the audio over the phone while watching the guide and activities in the virtual classroom on their computer Each class will last about an hour
All subjects will complete two additional surveys at approximately 9 weeks and 18 weeks after enrolling in the study
All subjects will complete two additional surveys at approximately 9 weeks and 18 weeks after enrolling in the study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None